Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp dge re-stenosis is a major problem following sirolimus-eluting stent (SES) implantation for the treatment of native coronary artery lesions. 1 To minimize the incidence of these events, longitudinal positioning of SES is considered to be critically important. Due to the current lack of a standard guideline, however, practitioners must decide the landing position by a somewhat arbitrary assessment in the actual clinical setting. The SIRIUS trial that used intravascular ultrasound (IVUS) to investigate lesions reported that the residual plaque burden is associated with edge re-stenosis. 2 Of particular interest, edge re-stenosis was mostly observed in cases of residual plaque area (PA)/volume >50% at the stent margins. According to these observations, we (1) determined unique stepwise IVUS criteria to achieve optimal longitudinal positioning of SES using plaque burden at the peri-stent margins, which might fit a variety of actual lesion subsets (Figure 1 ), and (2) have put them to practical use continuously. Because long-term clinical and angiographic outcomes are currently available, we verified these new criteria in terms of achievability and their actual impact on margin re-stenosis rates and long-term clinical outcomes.
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Methods

Study Population
From January 2005 to April 2006, 162 consecutive stable angina patients whose native coronary lesions were electively treated with SES were studied at Tokai University School of Medicine. SES were implanted according to the IVUS criteria ( Figure 1 ) of longitudinal stent positioning, which were determined with reference to the previous investigation. 2 A cut-off for plaque burden of <50% in the criteria was determined by either (1) visual assessment with reference to Figure 1 or (2) measurement by manual tracing using a software package installed in the IVUS console during the procedure. The consecutive patients who had completion of poststenting (after final balloon dilation) IVUS pullback were the subjects of the present study. Patients with native coronary Stenting and IVUS Imaging Protocols IVUS imaging was performed using a commercially available system (40 MHz; Boston Scientific, Natick, MA, USA) with automated pullback at 0.5 mm/s following intracoronary administration of 2.5 mg isosorbide dinitrate, and recorded on VHS video tape or CD for off-line quantitative and qualitative analyses. After acquisition and real-time evaluation of IVUS images, adequate stent diameter and length were determined with reference to the lumen diameter of a vessel of normal appearance or with fewer atherosclerotic segments with regard to our proposed criteria. The location of "stent landing" was determined by these stepwise logistics in the criteria. Basically, plaque burden, defined as PA/external elastic membrane (EEM) area ×100, <50%, meeting steps 1 and 2 of these criteria (Figure 1) , was considered as an optimal residual plaque burden at the SES margins.
Care was taken to avoid balloon injury, especially at the peri-stent margins to minimize delayed vascular responses. A pressure >16 atmosphere was recommended for final stent inflation. Follow-up coronary angiograms were routinely obtained at 8 months after stent implantation with the patient's agreement.
Quantitative Angiography
Serial quantitative coronary angiography (QCA) was obtained at pre-and post-intervention assessment and at the 8-month follow up. QCA was performed using computerassisted automated edge-detection (QCA-CMS 6.0, Medis, Leiden, the Netherlands). Using the external diameter of the contrast-filled guiding catheter as the calibration standard, the 3 subsegments (in-stent, 5-mm proximal margin, and 5-mm distal margin) were scrutinized under the established methodologies (DES-Brachy analysis mode). Percent diameter stenosis was calculated as minimal lumen diameter (MLD) divided by the reference diameter for each subsegment. Late loss was defined as post-procedural MLD minus follow-up MLD. Angiographic re-stenosis was defined as %diameter stenosis ≥50%.
Quantitative IVUS Analysis
Quantitative IVUS analysis was conducted using commercially available software (EchoPlaque2, Indec Systems, Mountain View, CA, USA) with the following steps. The cross-sections including the minimal stent area (MSA) site and the representative cross-sections of bilateral stent marginal segments were analyzed. Cross-sections of the proximal and distal margins were selected from sites of approximately average plaque burden within the 3-mm-margin segments adjacent to the bilateral stent edges. For the quantitative measurements, the border of lumen or stent and the EEM were manually traced by a well-trained physician, thus, the lumen area (LA), stent area, and EEM area were obtained. PA was calculated as the EEM area minus the LA at the same cross-section. Plaque burden was calculated as PA divided by EEM area multiplied Stepwise intravascular ultrasound (IVUS) criteria to determine optimal length and position of sirolimus-eluting stent (SES) and schematic representation of plaque burden of 50% as an optimal cut-off (upper limit) of these criteria. Once a user becomes familiar with this scheme, plaque burden of 50% may be easily distinguishable by visual estimation.
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by 100 for the proximal and distal stent margins. An achievement rate for steps 1 and 2 (plaque burden <50% at margins) was obtained for each of the proximal and distal margins.
Statistical Analysis
Statistical analysis was performed using JMP 7.02 (SAS Institute, Cary, NC, USA). Analyses were performed either on a per-patient or a per-lesion basis depending on the situation. Continuous variables are summarized as mean ± SD and qualitative data are presented as frequencies. When comparing 3 groups, the overall probability values were derived using the Kruskal -Wallis test. Comparisons between post-procedure and 8-month follow up were performed with the 2-tailed paired t-test. A receiver operating characteristic (ROC) curve was created to compare the diagnostic value of potential IVUS parameters for prediction of margin re-stenosis. P<0.05 was considered statistically significant.
Results
Overall Results
The baseline subject clinical characteristics are given in Table 1 . The mean age of the patient population was 66.8± 9.4 years and the majority of the patients were male (79.0%). The prevalence of diabetes was 42.6%, which is approximately the same as reported in other Japanese studies, 3-5 but higher than that in Western countries. 1,6-8 Similarly, there was a relatively high incidence of hypertension (76.5%). The prevalence of chronic kidney disease, defined as glomerular filtration rate <30 ml/min, was 10.5%, including chronic hemodialysis, which comprised 3.7% of all hemodialysis patients. The baseline lesion and procedural characteristics are also listed in Table 1 . Lesions fulfilling the definition of American Heart Association type B2/C were treated in 54.5% of the patients. The mean number of stents implanted was 1.36±0.63 and the mean diameter was 2.93±0.36 mm. Highpressure expansions were performed in all lesions and the mean pressure of expansion was 17.5±2.9 atmosphere. The sizes of balloons used were reasonably matched to lesion size or slightly bigger than lesion size, as judged necessary for successful implantation (balloon to artery ratio: 1.26±0.23).
Overall IVUS Results
A total of 144 proximal margins, 170 distal margins, and 180 MSA sites were accurately analyzable on quantitative IVUS. The reasons for exclusion from analysis for margins included ostial or bifurcated location, insufficient catheter passage, ambiguous EEM border due to severe calcification, and image protrusion due to inadequate IVUS zooming factor. Standard IVUS parameters are listed in Table 2 . Significant differences were observed in LA, EEM area, PA, and plaque burden between the 3 subsegments. At MSA sites, LA was the smallest and absolute PA and plaque burden were the largest among the 3 subsegments.
Evaluation of Impact of IVUS Guidance for Stent Positioning by Assessing Residual Plaque at Peri-Stent Margins
As described in the previous section, the optimal longitudinal stent position was determined by the proposed IVUS criteria with regard to segments with the least amount of plaque. Table 2 lists the main findings. Plaque burden was 41.4± MORINO Y et al. 13 .6% proximally and 34.8±15.6% distally. Absolute PA was 5.74±2.91 mm 2 at the proximal margin and 3.30±2.16 mm 2 at the distal margin. Accordingly, both ratio and absolute amount of residual PA were greater at the proximal margin than the distal margin. Frequency distribution of plaque burden is shown in Figure 2A . The results show that (1) plaque burden was disproportionately distributed and (2) plaque burden of the distal margin was distributed more to the left compared with that of the proximal margin. Importantly, the target (steps 1 and 2) was achieved at a high rate of 72.3% for the proximal and 84.1% for the distal margin for the criteria ( Figure 2B ). Interestingly, if we stratified the lesions according to presence or absence of diabetes mellitus (DM), that is, into a DM group and a non-DM group, the achievement rate of steps 1 and 2 was different between the 2 groups. Achievement rate of the DM group was significantly lower than that of the non-DM group at the distal margin (76.1% vs 89.9%, P=0.016). The achievement rate for the proximal margin was higher for the DM group than the non-DM group (66.1% vs 45.6%, P=0.213), but the difference was not statistically significant.
Clinical and Angiographic Outcomes
The 8-month clinical follow up was conducted for all patients (180 lesions, 162 patients). Follow-up angiography was done for 132 patients (81.5%, 147 lesions). Table 3 lists the clinical and angiographic outcomes at 8 months. The rate of major adverse cardiac events was strikingly low (4.35%), including a reasonable incidence of cardiac death (0.62%) or ST-elevation myocardial infarction (STEMI; 0.62%), and a notably low rate of target vessel revascularization (3.33%). One case of STEMI occurred at the non-stented lesion in the target vessel. Stent thrombosis was seen in only one patient (0.5%) at 29 days after stent implantation, who was under maintenance hemodialysis due to end-stage chronic kidney disease. One case of cardiac death was due to congestive heart failure Achievement rate of steps 1 and 2 of the criteria defined as plaque burden <50%. Overall, high rates were achieved at both margins. If the subjects were divided into 2 groups according to presence or absence of diabetes, the achievement rate was different between the 2 groups. DM, diabetes mellitus.
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in the patient who had severely impaired left ventricle function. The angiographic re-stenosis rate was strikingly low (in-lesion, 4.1%; in-stent, 0.7%; proximal margin, 2.7%; and distal margin, 1.4%) under the strategy based on the criteria. One patient had multifocal re-stenosis in-stent and at the proximal margin. Importantly, although the overall re-stenosis rate of peri-stent margin was acceptably low, further improvement was observed if the patients met steps 1 or 2 of the criteria (proximal margin, 1.4%; distal margin, 0%). All angiographic patterns of re-stenosis indicated focal re-stenosis. Serial angiographic measurements are given in Table 4 . Slight statistical changes were observed from post-intervention assessment to follow up in MLD and %diameter stenosis at the proximal margins and MSA sites. In contrast, no serial changes were observed in these parameters at the distal margins. Late lumen loss was small, including 0.09± 0.28 mm at the proximal margin, 0.01±0.28 mm at the distal margin, and 0.12±0.22 mm at the in-stent segment.
Comparison of Diagnostic Value of IVUS Parameters to Predict Margin Re-Stenosis and Optimal Threshold
The diagnostic values of IVUS parameters (LA, PA, and plaque burden) potentially influencing the angiographic or clinical outcomes at the peri-stent margin segments (combining proximal and distal margin) were compared. Figure 3 highlights the ROC curves of these parameters that could be used to predict margin re-stenosis. Area under the curve of plaque burden was the greatest among the 3 parameters (plaque burden, 0.88; PA, 0.79; LA, 0.61), supporting reasonability of use of plaque burden for determination of optimal stent landing in the present proposed IVUS criteria. Further- Comparison of the diagnostic value of representative intravascular ultrasound (IVUS) parameters to predict margin re-stenosis. Receiver operating characteristic (ROC) curves were created for each parameter and the area under the curve (AUC) was calculated. Plaque burden had the strongest diagnostic value among these parameters. The optimal threshold to predict margin re-stenosis was estimated as plaque burden of 51.6% on this ROC curve.
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more, the estimated optimal cut-off of plaque burden to predict margin re-stenosis was 51.6% for this ROC curve.
Impact of Peri-Stent Residual Plaque Burden on In-Stent Late Loss
The impact of peri-stent residual plaque burden on angiographic in-stent late loss was investigated. We divided the lesions into 3 groups as follows: lesions with plaque burden at both margins <50% (n=103), those with plaque burden ≥50% at either margin (n=33), and plaque burden ≥50% at both margins (n=10). Interestingly, in-stent late loss was significantly greater in the lesions with plaque burden ≥50% (0.30±0.07 mm), compared with those with plaque burden ≥50% at either margin (0.13±0.16 mm) and those with plaque burden <50% at both margins (0.09±0.12 mm; P=0.0014). Therefore, peri-stent residual plaque burden has an impact on in-stent angiographic late loss.
Discussion
Advantages of Determination of Optimal Stent Landing
The results of the SIRIUS trial demonstrated that peri-stent margin re-stenosis is one of the problems of SES, which have an overall re-stenosis rate of 64.5%. 1 A similar phenomenon has been observed in the early phase of a paclitaxel-eluting stent trial, the TAXUS-II trial, which found a re-stenosis rate of 50% at the stent-margins. 9 Accordingly, peri-stent margin re-stenosis is a common, 10 significant problem of drug-eluting stents that needs to be overcome. Historically, Mintz et al reported that only 6.8% of the angiographically normal reference segments were found to be normal on IVUS, and the percent cross-sectional narrowing averaged 51%. 11 Thus, a potential advantage of using IVUS prior to and/or during the procedure is the ability to accurately assess plaque distribution axially and longitudinally. In addition, Sakurai et al suggested that a larger percentage of PA was associated with edge stenosis in the SES cohort. 2 In that study they concluded that full lesion coverage and matching of the stented segment properly to the adjacent segment using IVUS guidance may further improve SES implantation efficacy. Asano et al. demonstrated that baseline PA was associated with edge re-stenosis by influencing vascular remodeling. 12 These two IVUS studies demonstrated the importance of quantitative assessment of absolute or relative PA around the stent landing zones during the procedures. In contrast, however, to the established criteria or the well-known findings related to optimal stent expansion, 13-16 those related to optimal stent positioning remain limited. Currently, one informative study exists that supports our proposed criteria by comparing bare metal stent (BMS) and paclitaxeleluting stent (TAXUS) in the large clinical trials (TAXUS IV, V, and VI). In that study Liu et al concluded that residual plaque burden predicts stent edge re-stenosis after BMS and TAXUS stents, independent of vessel size and edge lumen dimension. 17 Further studies under the following conditions (1) other representative DES usage and (2) more realistic clinical situations, are required to establish a universal IVUS guideline for determination of optimal DES landing.
Verification of the Proposed IVUS Criteria
In the present study the ROC curves indicated that plaque burden was the strongest predictor of SES margin re-stenosis among all the potential IVUS parameters (PA, plaque burden, LA). Similar investigations were conducted for paclitaxeleluting stents and BMS. 17 Therefore, regardless of the stent category or type, plaque can be used as the primary target for the stent landing position under IVUS guidance. ROC curve assessment indicated that the optimal threshold for prediction was plaque burden of 51.6%, despite a small sample size. This cut-off is nearly identical to that of our initial criteria of 50%. Furthermore, this condition (plaque burden <50%) could be achieved in the majority of cases. We believe that most operators would accept this degree of achievability.
Indirect Comparison With the Representative Domestic Registry Reflected Actual Clinical Practice
Because the present study did not have a control arm, other representative studies that reflect Japanese actual clinical practice may be informative for more profound discussion. Currently, the Japanese Cypher Post-Market Surveillance (J-PMS) registry (n=2459 lesions) may be a good candidate. 18 In the present study serial angiographic assessments were available in 983 lesions at an independent core laboratory. Table 5 lists the clinical and angiographic comparisons between IVUS guidance (n=737) and angiography guidance (n=250). Interestingly, a statistically significant difference was observed in the re-stenosis rate at the distal margins; there was also a difference at the proximal margins but the difference was not statistically significant. In contrast, no difference was observed in the in-stent re-stenosis rate between the 2 groups. These data suggest that IVUS may be a useful tool to reduce SES margin re-stenosis. Moreover, the present study using Tables 1,3 .
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uniform IVUS criteria demonstrated a possibility of further decrease in the absolute re-stenosis rate at both the marginal and in-stent segments compared with the J-PMS registry, although no statistic comparisons are available. Future trials using a prospective randomized design are needed to confirm the results.
Potential Concerns Under Actual Clinical Conditions
Some practitioners may think that they would use more or longer stents if they use the criteria. But as the present results show, on average 1.36 stents with an average stent length of 21.9 mm were actually implanted according to the criteria, which can be considered as reasonable for most operators. The majority of cases involved some discontinuous portions in plaque distribution, which could be used for optimal landing. Limitation of the line-up of stents (mostly at 4-or 5-mm intervals) would be more problematic in some situations than finding segments with less plaque.
New Considerations and Speculations Related to SES Re-Stenosis From the IVUS Viewpoint
We learned several lessons from this investigation. First, the constant efforts to find sites with less plaque for stent landing produced a small mean plaque burden of 37.8% (41.4% at proximal margin and 34.8% at distal margin), compared with the SIRIUS dataset in which a similar parameter was estimated as 49.2%. 2 We prospectively showed that our procedures following these criteria successfully resulted in a reasonably low rate of margin re-stenosis and/or revascularization. Second, it has been consistently observed that edge restenosis more commonly occurs in the proximal margin. 1, 19 One potential mechanism was speculated to be the blood flow direction affecting the local concentration of sirolimus, so that distal margins received more drug elution than the proximal margins. We currently believe, however, that another dominant factor exists, that is, it is more difficult to find fewer portions with less plaque burden at the proximal margins due to more plaque accumulation or existence of important side branches. Despite our best efforts, plaque burden at the proximal margins was significantly greater than that of the distal margins. Even under careful IVUS guidance, approximately 30% of proximal margin sites did not satisfy the criteria of plaque burden <50% in the actual clinical setting.
Third, it tends to be more difficult to find an optimal landing zone in patients with diabetes, which may be primarily due to diffuse progression of atherosclerotic plaque. It may also be a potential cause of higher re-stenosis rates after SES implantation. 20 Several reports focusing on diabetes and SES produced varied results with regard to long-term outcome. 20- 22 The reasons for such discrepancy are thought to be differences in accuracy of optimal stent landing between the studies. In diabetic patients, such a variety of implantation techniques may strongly impact on the resultant late outcomes due to an increased rate of margin re-stenosis.
Fourth, residual plaque burden at the peri-stent margin also affects in-stent neointimal responses. Characteristic longitudinal distribution of neointima was observed in the SIRIUS trial (more growth of in-stent neointima around both stent edges). 23 The cause of these observations might be partially explained by the present results. Finding a better portion for SES landing is important to suppress excessive vascular reactions not only at the peri-stent margin but also within the in-stent segments.
Study Limitations
The study group was relatively small. Additional prospective investigations with larger groups of patients are warranted to confirm the results. There was no control group in the present study (eg, BMS group, non-IVUS guidance group, or reference criteria group). Under the current clinical practice, however, randomization with BMS may be ethically unacceptable. This reason also applies to randomization in studies in which IVUS is used under the current Japanese code of clinical practice. For reference, we used data from the representative, large scale, multicenter registry in Japan (J-PMS) to allow indirect comparison and provide a basis for discussion of the findings.
Conclusions
The proposed stepwise IVUS criteria mainly targeting plaque burden <50% at stent margins are feasible and useful for real-world SES implantation, which may potentially improve margin re-stenosis rates and long-term clinical outcomes. Further clinical evaluations should be conducted to test the adequateness of the proposed criteria and are important to establish universal IVUS guidelines.
